Abstract
Achievement of European atherosclerosis society (EAS) targets with lomitapide, a microsomal transfer protein inhibitor in homozygous familial hypercholesterolaemia (HoFH)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have